| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 154,358 | 149,204 | 134,066 | 133,528 |
| Cost of revenue | 35,553 | 34,349 | 30,126 | - |
| Sales and marketing | 36,317 | 35,798 | 32,128 | 30,144 |
| Technology and development | 22,632 | 20,099 | 19,700 | 16,840 |
| General and administrative | 33,715 | 26,546 | 26,196 | 25,348 |
| Cost of revenue (excluding depreciation and amortization shown below) | - | - | - | 27,373 |
| Depreciation and amortization | 17,900 | 17,242 | 16,463 | 16,243 |
| Foreign exchange loss (gain), net | 667 | -5,782 | -1,998 | -2,607 |
| Total operating expenses | 146,784 | 128,252 | 122,615 | 113,341 |
| Operating income | 7,574 | 20,952 | 11,451 | 20,187 |
| Interest income (expense), net | 595 | 157 | -72 | -1,325 |
| Net income before income taxes | 8,169 | 21,109 | 11,379 | 18,862 |
| Provision for income taxes | 1,124 | 4,701 | 3,386 | 2,773 |
| Net income | 7,045 | 16,408 | 7,993 | 16,089 |
| Foreign currency translation adjustments | 94 | 3,306 | 1,806 | 892 |
| Total comprehensive income | 7,139 | 19,714 | 9,799 | 16,981 |
| Basic (in shares) | 166,473,735 | 165,018,978 | 163,646,444 | 161,663,506 |
| Diluted (in shares) | 169,800,709 | 167,347,688 | 166,811,853 | 165,084,108 |
| Net income per share - basic (in dollars per share) | 0.04 | 0.1 | 0.05 | 0.1 |
| Net income per share - diluted (in dollars per share) | 0.04 | 0.1 | 0.05 | 0.1 |
INTEGRAL AD SCIENCE HOLDING CORP. (IAS)
INTEGRAL AD SCIENCE HOLDING CORP. (IAS)